Intravesical sequential gemcitabine and docetaxel versus bacillus calmette-guerin (BCG) plus interferon in patients with recurrent non-muscle invasive bladder cancer following a single induction course of BCG

Ryan L. Steinberg, Vignesh T. Packiam, Lewis J. Thomas, Nathan A. Brooks, Andrew Vitale, Sarah L. Mott, Trafford Crump, Jonathan Wang, William C. DeWolf, Donald L. Lamm, Max Kates, M. Eric Hyndman, Ashish M. Kamat, Trinity J. Bivalacqua, Kenneth G. Nepple, Michael A. O’Donnell